47 results
Page 2 of 3
8-K
EX-99.1
lnf tzt3p
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am
8-K
EX-99.1
4hzdmhylupvd1dzjt
4 Dec 20
Regulation FD Disclosure
9:07am
8-K
EX-99.1
ggel6
25 Nov 20
Equillium Provides Itolizumab COVID-19 Program Update
8:01am
8-K
EX-99.1
whgiz96
10 Nov 20
Equillium Reports Third Quarter 2020 Financial Results and Business Highlights
4:11pm
8-K
EX-99.1
btm71lkj1mcf 9u
29 Oct 20
Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial
5:12pm
8-K
EX-99.1
94mlkutsef
13 Jul 20
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon
6:05am
8-K
EX-99.1
l1yc wdi8hz
12 Dec 19
Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to
7:05am
8-K
EX-99.2
sstox qrnrxbmv5
12 Nov 19
Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights
4:10pm
8-K
EX-99.1
3ffmqbh5
1 Oct 19
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
9basv2tg
1 May 19
Regulation FD Disclosure
12:00am
10-K
5uwt0gd h7ep
27 Mar 19
Annual report
4:11pm
8-K
EX-99.2
7a9qt5l75th86da
26 Feb 19
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
2rjgpd6yyl1evp57ty77
26 Feb 19
Results of Operations and Financial Condition
4:05pm